drugset / Trial / NCT02244866
Efficacy of Pergoveris in Aged IVF Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the efficacy between LH supplementation (Pergoveris) and non-LH supplementation (Follitropin alpha) in patients aged ≥ 35 years undergoing IVF treatment. Study hypothesis: Pergoveris (LH supplementation) is better than follitropin alpha (non-LH supplementation) for ovarian stimulation in aged IVF patients.
Timeline
- Start
- 2012-10
- Primary completion
- 2014-04
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gonal-f | Protein / enzyme biologic | 150 iu | Subcutaneous |
| Comparator | Recombinant LH | Protein / enzyme biologic | 75 iu | Subcutaneous |